USE OF 13C-CORTISOL TO DETERMINE THE CORTISOL PRODUCTION RATE (CPR) IN CONGENITAL ADRENAL
HYPERPLASIA DUE TO 17-ALPHA-HYOROXYLASE DEFICIENCY.
1,2,3,4-13C cortisol(l3C-F) was used to measure the CPR in two sisters(karyotype 46,XX)of 11(I) and 3(II) yrs of age with 17a-hydroxylase deficiency. The disease was diagnosed on hyper tension, low plasma conc. of 170-estradiol,cortisol, PRA and aldosterone and high conc. of progesterone and in patient I of ACTH, FSH and LH. Both children excreted in the urine high amounts of tetra-and hexahydro-metabolites of corticosterone and deoxycorticosterone and (very) low amounts of metabolites of cortisol (F), androstenedione and testosterone.
After the i.v. dosage of 60 and 2.4 pg to patient I and 11, urine was collected for 3 days. After extraction, hydrolysis and HPLC Chromatography the metabolites of F were oxidised to ll-oxoetiocholanolone ( 11-OET) and -androsterone.The 13C-enrichments in the methoxime-tert.butyldimethy1sily ethers were measured by gas chromatography mass fragmentography at the leading ions mlz 348 (13C4) and 344 (12C). Calibration standards were prepared from mlxtures of 13C-F and F, which were oxidised to cortisone (E), reduced to tetrahydrocortisone (THE) by Cl.paraputrificum and oxidised to 11-OET. The CPR (mglday) was for I:0.28+0.003 (THE) and 0.19+0.007 (at~cortolone) and for I1 :0.022+0.003 (THE).
Owing to the very low amounts of cortisol metabolites the CPR determinations would not have been possible if tritiated cortisol was used. Second trimester amniotic fluid was analysed from 54 pregnancies at risk of fetal 21-hydroxylase deficiency; the outcome is currently knoun in 46. Analysis of samples from a further 96 normal outcome pre nancies provided a reference range for 17P. The assay used an 1951-radioligand and an antiserum raised against a 17P-3-CMO-BSA conjugate coupled to a mawtisable, solid-phase support. Mean f SD 17P values uere: normals, 18.5~ 5.2 nmol/l (range 9.8 -30.7); predicted unaffected, 17.4 f 6.5 (9.4 -31.3, n = 37); predicted affected, 64.2 f 46.3 (30 -170, n = 9; p<0.001). Unaffected pregnancies produced all normal infants at birth, but a male non-salt loser had increased 17P Levels at 3 months. Four of 9 predicted pregnancies uere terminated, 1 affected male died at 2 weeks after preterm delivery; in the remaining 4 term pregnancies, 21OHD uas confirmed postnatally in 3 and excluded in 1 by a normal plasma 17P. Family HLA typing shoued he uas a heteroz~gote. Information on 44 index cases shoved 61% females and 77% salt-losers; 8 of these had died in infancy. All fetuses in this study predicted to be affected uere salt-losers. Thus prenatal steroid analysis is reliable only for this vulnerable group. Preliminary data from the Literature indicates that use of current 21OH gene probes may not be any more specific in the diagnosis of the precise phenotype. were high in the newborn period and decreased with age (group I vs. I1 and 111: ~0.02). Concentrations of DHEA-S as a marker of the fetal zone of the adrenal showed a negative correlation with chronological age (r=-0.62; p<0.0001) and differed significantly in the 3 age groups (p<0.05). In a boy with CAH due to 21-hydroxylase-deficiency, diagnosed prenatally, AS1 were above the normal range for age during the first days of life and returned to normal with treatment. In conclusion, AS1 are helpful in the clinical diagnosis of adrenal diseases in the newborn period. Reference ranges are given for newborns and infants during the first year of life. Comparison of DHEA-S concentrations and adrenal size in vivo as determinad by ultrasound, is consistent with the fact that decrease in adrenal size shortly after birth is due to involution of the fetal zone.
E It has been reported that prenatal dexamethasone (DEX) treatment of women carrying female CAH fetuses suppresses fetal adrenal function and prevents virilization of external genita1ia.m 2 CAH families,the mothers were treated in their 2nd pregnancies with DEX (lmg/d) from week 1O.Dex was stopped 5 d before amniocentesis (wk 171,then resumed until delivery. Both fetuses (46,XX) had high amniotic fluid 170HP levels (10.5, 10.4;normal range:1.2-3.8 ng/ml) suggestive of homozygous 21-OHase def.Pregnancies and deliveries (term) were normal.Both newborns were virilized (Prader IV).Plasma levels of progesterone (P),17-hydroxyprogesterone (170HP),aldosterone (Aldo),cortisol,estriol and DEX were measured by specific RIAs in Pat.1 from wk 17,in Pat. 2 from wk 25 until delivery.Results (Pat.l/Pat.2) in ng/ml. wk P 170HP Aldo Estriol Cortisol DEX Plasma Adiol-C values, considered as a good marker of peripheral androgen conversion in adults, have not yet been reported in children. Adiol-C uas measured in plasma aqueous phase left after ether extraction of unconjugated steroids. The method included B-glucuronidase hydrolysis, ether extraction, celite collrmn chromatography and specific RIA. The results, in 150 normal children and 33 adults. are given in ng/dl (meaniS0). In adults. Adlol-C levels were significantly higher ( p <0.001) in males (436i174) than in females (135i74). In children 1-6 years old, Adiol-C was low without sex difference: 21.2i9.8 in boys, 19.9i6.6 in girls. Then, Adlol-G levels rose progressively: 43.9i13.8 in boys and 47.8i18 in girls 9-11 years old. After the age of 11, Adlol-C rose significantly and more rapidly in boys than in girls: 72.7i39 in boys vs 52.9i17 in girls from 11 to 13 years and 158.8i68 in boys vs 76i4.8 in girls from 13 to 15 years. Adult values were observed at age 15-16 in girls, while in boys, Adiol-C levels continued to rise till adulthood. In 3 boys, age 13.6 to 19, with complete adrenal insufficiency and normal pubertal developnent, values of Adiol-G uere normal for age. The Adlol-C rise observed at the end of an hCC test (204i159) in 12 boys (1-11 yrs) and the high values found in untreated CAH, 528i267 in 12 infants and 216.6i102 in 7 girls (1-6 yrs) suggest that Adlol-G could be used as a parameter of androgen metabolism in childhood. 
